Durvalumab in urothelial cancers
Sign Up to like & getrecommendations! Published in 2018 at "Expert Review of Anticancer Therapy"
DOI: 10.1080/14737140.2018.1443812
Abstract: ABSTRACT Introduction: Urothelial bladder cancer is one of the most predominant malignancies worldwide with a poor prognosis when presented at an advanced or metastatic stage. Improving the therapeutic landscape in this setting has been an… read more here.
Keywords: durvalumab urothelial; bladder cancer; urothelial cancers;